Study Comparing Single Doses of Abrocitinib Tablets and Abrocitinib Liquid Medicine Taken Alone and After Famotidine Antacids. A Phase 1, Randomized, Crossover Study to Evaluate Relative Bioavailability of Abrocitinib Oral Suspension and Effect of an Acid-Reducing Agent on the Bioavailability of Abrocitinib Commercial Tablet and to Assess the Taste of Abrocitinib Oral Formulations in Healthy Adult Participants
Aged 18 to 55 Years of Age.